Following Recalls, Digitek Manufacturer to Remain Shut Down

The U.S. Department of Justice and the FDA have taken steps to continue barring Actavis Totowa from manufacturing and distributing generic drugs. The actions were taken following a series of serious manufacturing problems which resulted in a nationwide Digitek recall earlier this year when double strength tablets were produced, and a subsequent recall that involved potential issues with over 65 different generic drugs.

On November 14, 2008, the Justice Department announced that the United States government has filed a lawsuit seeking a permanent injunction against Actavis Totowa LLC, their parent company Actavis Inc. and two of the company’s executives, barring them from manufacturing and distributing generic drugs until they can demonstrate their ability to comply with the Good Manufacturing Practice requirements of the Federal Food, Drug and Cosmetic Act.

Actavis Totowa has received a number of warnings for distributing adulterated and misbranding drugs, and the FDA has found numerous, recurring violations of Good Manufacturing Practices during their inspections of the company’s facilities.

Did You Know?

AT&T Data Breach Impacts Millions of Customers

More than 73 million customers of AT&T may have had their names, addresses, phone numbers, Social Security numbers and other information released on the dark web due to a massive AT&T data breach. Lawsuits are being pursued to obtain financial compensation.

Learn More

In April 2008, manufacturing problems at Actavis Totowa’s plant in New Jersey resulted in a recall of Digitek tablets, a generic form of digoxin , which were twice as thick as they were supposed to be and contained up to twice the appropriate active ingredient.

As a result of the Digitek problems, hundreds of users have claimed that they suffered serious injury, such as renal impairment, cardiac arrhythmias and death, caused by digoxin overdose. A number of these users have filed Digitek lawsuits against Actavis and their distributors, and additional lawsuits are being filed every week.

On August 1, 2008, Actavis Totowa was also forced to recall over 65 different generic drugs due to non-compliance with Good Manufacturing Practice requirements at the same New Jersey plant. Although Actavis has claimed that these tablets do not pose any health risks, the FDA required them to recall millions of generic painkillers, antidepressants, hypertension, blood pressure and diet drugs.

The Department of Justice filed for the permanent injunction after Actavis Totowa recently informed the FDA that they wanted to restart manufacturing of drug products. However, the FDA still does not believe that they have demonstrated that they can follow the Good Manufacturing Practice requirements.

Actavis Totowa has indicated that they view the action as one step in a long process of regulation and they claim that they remain fully committed to collaborating with the FDA to ensure that their facilities and products comply with Federal regulations.

Image Credit: |

1 Comments

  • BruceNovember 18, 2008 at 3:56 pm

    Well the Department of Justice Can not shut down this company without shutting down KV Pharmicies because KV has had five recalls and no inspections and has killed more people that Actavis. Why pick on these guys? Is K-V and Ethex favoriate children or big contributors to the campaign? NO NO NO, Is it because a Lawyer named Lawrence Brody of the Bryan Cave Law Firm ownes almost five million share[Show More]Well the Department of Justice Can not shut down this company without shutting down KV Pharmicies because KV has had five recalls and no inspections and has killed more people that Actavis. Why pick on these guys? Is K-V and Ethex favoriate children or big contributors to the campaign? NO NO NO, Is it because a Lawyer named Lawrence Brody of the Bryan Cave Law Firm ownes almost five million shares? Come on Department of Justice, Do not shut them down.

Share Your Comments

I authorize the above comments be posted on this page*

Want your comments reviewed by a lawyer?

To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.

NOTE: Providing information for review by an attorney does not form an attorney-client relationship.

This field is for validation purposes and should be left unchanged.

More Top Stories

Gilead Settlement Resolves 2,625 HIV Drug Lawsuits Pending in Federal Courts for $40M
Gilead Settlement Resolves 2,625 HIV Drug Lawsuits Pending in Federal Courts for $40M (Posted yesterday)

Gilead says it will pay $40 million to resolve HIV drug lawsuits over Truvada, Atripla, Viread, Stribild and Complera pending in the federal court system, involving claims that the the company sat on safer formulations of the drugs for years to increase profits.

Gardasil Vaccine Lawsuits Being Prepared For Early Test Trials in Federal MDL
Gardasil Vaccine Lawsuits Being Prepared For Early Test Trials in Federal MDL (Posted 2 days ago)

In advance of a a conference this week, lawyers report that progress is being made to prepare a group of federal Gardasil vaccine lawsuits for early test trials, to help gauge how juries may respond to certain evidence and testimony that will be repeated throughout the litigation.